124 related articles for article (PubMed ID: 31571404)
1. Sustained remission in a patient with PDGFR-beta-rearranged T-lymphoblastic lymphoma and complete remission with dasatinib.
Shah KP; Carroll CM; Mosse C; Yenamandra A; Borinstein SC
Pediatr Blood Cancer; 2020 Jan; 67(1):e28026. PubMed ID: 31571404
[No Abstract] [Full Text] [Related]
2. Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
Tsurusaki Y; Nagai JI; Fujita S; Sugiyama M; Nakamura W; Hayashi A; Miyagawa N; Keino D; Yokosuka T; Iwasaki F; Hamanoue S; Shiomi M; Goto S; Kurosawa K; Goto H
Pediatr Blood Cancer; 2020 Jan; 67(1):e28019. PubMed ID: 31556219
[No Abstract] [Full Text] [Related]
3. Dasatinib-therapy induced sustained remission in a child with refractory TCF7-SPI1 T-cell acute lymphoblastic leukemia.
He Y; Zhang J; Zhang Y; Hu Z; Wang P; Gan W; Xie S; Qian M; Pui CH; Jiang H; Zhu X; Zhang H; Zhang W
Pediatr Blood Cancer; 2022 Aug; 69(8):e29724. PubMed ID: 35441457
[TBL] [Abstract][Full Text] [Related]
4. Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.
Crombet O; Lastrapes K; Zieske A; Morales-Arias J
Pediatr Blood Cancer; 2012 Aug; 59(2):333-4. PubMed ID: 22689211
[TBL] [Abstract][Full Text] [Related]
5. A novel
Zabriskie MS; Antelope O; Verma AR; Draper LR; Eide CA; Pomicter AD; Tran TH; Druker BJ; Tyner JW; Miles RR; Graham JM; Hwang JY; Varley KE; Toydemir RM; Deininger MW; Raetz EA; O'Hare T
Haematologica; 2018 Feb; 103(2):e87-e91. PubMed ID: 29284681
[No Abstract] [Full Text] [Related]
6. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
[No Abstract] [Full Text] [Related]
7. Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm.
Cerrano M; Crisà E; Gottardi E; Aguzzi C; Boccadoro M; Ferrero D
Am J Hematol; 2016 Sep; 91(9):E353. PubMed ID: 27194679
[No Abstract] [Full Text] [Related]
8. Nodular lesions of the scalp and a mediastinal mass in T cell acute lymphoblastic leukemia.
Konik A; Dührsen U; Röth A
Int J Hematol; 2010 Jul; 92(1):3-4. PubMed ID: 20559760
[No Abstract] [Full Text] [Related]
9. Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib.
Sekimizu M; Yamashita Y; Ueki H; Akita N; Hattori H; Maeda N; Horibe K
Leuk Lymphoma; 2014 Jul; 55(7):1652-3. PubMed ID: 24024475
[No Abstract] [Full Text] [Related]
10. Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
Shimomura Y; Maruoka H; Ishikawa T
Int J Hematol; 2017 May; 105(5):697-701. PubMed ID: 28000100
[TBL] [Abstract][Full Text] [Related]
11. Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia.
Milani G; Matthijssens F; Van Loocke W; Durinck K; Roels J; Peirs S; Thénoz M; Pieters T; Reunes L; Lintermans B; Vandamme N; Lammens T; Van Roy N; Van Nieuwerburgh F; Deforce D; Schwab C; Raimondi S; Dalla Pozza L; Carroll AJ; De Moerloose B; Benoit Y; Goossens S; Berx G; Harrison CJ; Basso G; Cavé H; Sutton R; Asnafi V; Meijerink J; Mullighan C; Loh M; Van Vlierberghe P
Br J Haematol; 2019 Apr; 185(1):169-174. PubMed ID: 29938777
[No Abstract] [Full Text] [Related]
12. Complete remission with romidepsin in a patient with T-cell acute lymphoblastic leukemia refractory to induction hyper-CVAD.
Brunvand MW; Carson J
Hematol Oncol; 2018 Feb; 36(1):340-343. PubMed ID: 28560733
[TBL] [Abstract][Full Text] [Related]
13. Importance of Acute Lymphoblastic Leukemia-type Therapy for Bilineal Acute Leukemia.
Nakagawa S; Okamoto Y; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
J Pediatr Hematol Oncol; 2019 Aug; 41(6):504-506. PubMed ID: 30198961
[TBL] [Abstract][Full Text] [Related]
14. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
[TBL] [Abstract][Full Text] [Related]
15. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Deenik W; Beverloo HB; van der Poel-van de Luytgaarde SC; Wattel MM; van Esser JW; Valk PJ; Cornelissen JJ
Leukemia; 2009 Mar; 23(3):627-9. PubMed ID: 18987655
[No Abstract] [Full Text] [Related]
16. In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia.
Glover JM; Loriaux M; Tyner JW; Druker BJ; Chang BH
Pediatr Blood Cancer; 2012 Sep; 59(3):576-9. PubMed ID: 22038978
[TBL] [Abstract][Full Text] [Related]
17. T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia.
Kim H; Kim IS; Chang CL; Kong SY; Lim YT; Kong SG; Cho EH; Lee EY; Shin HJ; Park HJ; Eom HS; Lee H
Ann Lab Med; 2019 Mar; 39(2):125-132. PubMed ID: 30430774
[TBL] [Abstract][Full Text] [Related]
18. A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Papayannidis C; DeAngelo DJ; Stock W; Huang B; Shaik MN; Cesari R; Zheng X; Reynolds JM; English PA; Ozeck M; Aster JC; Kuo F; Huang D; Lira PD; McLachlan KR; Kern KA; Garcia-Manero G; Martinelli G
Blood Cancer J; 2015 Sep; 5(9):e350. PubMed ID: 26407235
[No Abstract] [Full Text] [Related]
19. Successful outcome of disseminated Candida tropicalis osteomyelitis on remission induction for childhood Philadelphia chromosome-positive acute lymphoblastic leukaemia-case report.
Xie L; Long Q; Zhou G; Liu S; Wen FQ
Ital J Pediatr; 2021 Feb; 47(1):27. PubMed ID: 33573668
[TBL] [Abstract][Full Text] [Related]
20. Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib.
Biagi C; Astolfi A; Masetti R; Serravalle S; Franzoni M; Chiarini F; Melchionda F; Pession A
Leukemia; 2010 Jun; 24(6):1230-3. PubMed ID: 20428205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
